RA CAPITAL MANAGEMENT, LLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RA CAPITAL MANAGEMENT, LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RA CAPITAL MANAGEMENT, LLC. RA CAPITAL MANAGEMENT, LLC is a 10% Owner in LIPID SCIENCES INC/ ($LIPD) and a Director in KalVista Pharmaceuticals, Inc. ($CBYL) and a 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and a Director in Dicerna Pharmaceuticals Inc ($DRNA) and a Director in Kala Pharmaceuticals, Inc. ($KALA) and a Director in Ra Pharmaceuticals, Inc. ($RARX) and a 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and a in G1 Therapeutics, Inc. ($GTHX) and a 10% Owner in Synthorx, Inc. ($THOR) and a 10% Owner in scPharmaceuticals Inc. ($SCPH) and a Director in Wave Life Sciences Ltd. ($WVE) and a in ARVINAS INC. ($ARVN) and a 10% Owner in IMARA Inc. ($IMRA) and a Director in Satsuma Pharmaceuticals, Inc. ($STSA) and a Director in Eidos Therapeutics, Inc. ($EIDX) and a 10% Owner in Phathom Pharmaceuticals, Inc. ($PHAT) and a Director in 89bio, Inc. ($ETNB).

Address: 111 HUNTINGTON AVENUE, SUITE 610 BOSTON 02199 MA

Companies in which RA CAPITAL MANAGEMENT, LLC is an Insider

89bio, Inc.

Trading Symbol: ETNB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 1,500,000 shares
Latest Transaction: Nov 13 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 8x
Sell: 0x
Shares Bought: 12,644,856
Shares Sold: 0
Share Difference: +12,644,856
Value Difference: -$96,000,000

Aclaris Therapeutics, Inc.

Trading Symbol: ACRS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 2,607,719 shares
Current Value: $65,844,905
Latest Transaction: Sep 19 2016
$ACRS Market Capitalization: $537.94M
$ACRS Previous Close: $25.25

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 5x
Shares Bought: 0
Shares Sold: 525,550
Share Difference: -525,550
Value Difference: +$12,713,502

ARVINAS, INC.

Trading Symbol: ARVN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC:
Holdings: 1,847,002 shares
Latest Transaction: Oct 03 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 3,138,412
Shares Sold: 0
Share Difference: +3,138,412
Value Difference: -$16,000,000

Dicerna Pharmaceuticals Inc

Trading Symbol: DRNA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner, Director
Holdings: 5,074,013 shares
Current Value: $13,090,954
Latest Transaction: Dec 20 2017
$DRNA Market Capitalization: $50.84M
$DRNA Previous Close: $2.58

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 2,645,442
Shares Sold: 0
Share Difference: +2,645,442
Value Difference: $0

Eidos Therapeutics, Inc.

Trading Symbol: EIDX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 1,103,847 shares
Latest Transaction: Jun 22 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 4,325,342
Shares Sold: 0
Share Difference: +4,325,342
Value Difference: -$36,000,016

G1 Therapeutics, Inc.

Trading Symbol: GTHX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC:
Holdings: 1,723,304 shares
Latest Transaction: May 24 2017

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 2,684,244
Shares Sold: 0
Share Difference: +2,684,244
Value Difference: -$6,000,000

IMARA Inc.

Trading Symbol: IMRA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 829,348 shares
Latest Transaction: Mar 17 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 1,454,348
Shares Sold: 0
Share Difference: +1,454,348
Value Difference: -$10,000,000

Kala Pharmaceuticals, Inc.

Trading Symbol: KALA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 10,874,613 shares
Latest Transaction: Mar 13 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 5x
Sell: 0x
Shares Bought: 13,298,855
Shares Sold: 0
Share Difference: +13,298,855
Value Difference: -$97,999,983

KalVista Pharmaceuticals, Inc.

Trading Symbol: KALV
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 1,441,070 shares
Latest Transaction: Oct 16 2017

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 1,441,070
Shares Sold: 0
Share Difference: +1,441,070
Value Difference: -$7,225,000

LIPID SCIENCES INC/

Trading Symbol: LIPD
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 3,713,962 shares
Latest Transaction: Mar 28 2007

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Phathom Pharmaceuticals, Inc.

Trading Symbol: PHAT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 3,676,808 shares
Latest Transaction: Mar 31 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 60,600
Shares Sold: 0
Share Difference: +60,600
Value Difference: -$1,489,264

Ra Pharmaceuticals, Inc.

Trading Symbol: RARX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 03 2020
$RARX Market Capitalization: $405.38M
$RARX Previous Close: $18.17

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Last 3 Months Overview:
Buy: 5x
Sell: 1x
Shares Bought: 4,858,260
Shares Sold: 4,858,260
Share Difference: 0
Value Difference: +$200,496,480

Satsuma Pharmaceuticals, Inc.

Trading Symbol: STSA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 2,008,409 shares
Latest Transaction: Sep 17 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 4,681,858
Shares Sold: 0
Share Difference: +4,681,858
Value Difference: -$19,999,996

scPharmaceuticals Inc.

Trading Symbol: SCPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 3,247,005 shares
Latest Transaction: Apr 15 2019

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 389,862
Shares Sold: 0
Share Difference: +389,862
Value Difference: -$1,052,627

Synthorx, Inc.

Trading Symbol: THOR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Jan 24 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 1x
Shares Bought: 9,724,598
Shares Sold: 9,724,598
Share Difference: 0
Value Difference: +$611,272,636

Wave Life Sciences Ltd.

Trading Symbol: WVE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director
Holdings: 7,775,207 shares
Current Value: $224,314,722
Latest Transaction: Jan 28 2019
$WVE Market Capitalization: $681.95M
$WVE Previous Close: $28.85

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 686,556
Shares Sold: 0
Share Difference: +686,556
Value Difference: -$19,881,554

Latest Insider Trading Transactions of RA CAPITAL MANAGEMENT, LLC

Sentiment: All, ETNB, ACRS, ARVN, DRNA, EIDX, GTHX, IMRA, KALA, KALV, LIPD, PHAT, RARX, STSA, SCPH, THOR, WVE

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 03 2020RARXRa Pharmaceuticals ...RA CAPITAL MANAGEMENT, L.P.DirectorSellD48.004,858,260233,196,48004.9 M to 0 (-100.00 %)
Mar 31 2020PHATPhathom Pharmaceut ...RA CAPITAL MANAGEMENT, L.P.10% OwnerBuyP24.5530,600751,2643,707,4083.7 M to 3.7 M (+0.83 %)
Mar 31 2020PHATPhathom Pharmaceut ...RA CAPITAL MANAGEMENT, L.P.10% OwnerBuyP24.6030,000738,0003,676,8083.6 M to 3.7 M (+0.82 %)
Mar 17 2020IMRAIMARA Inc.RA CAPITAL MANAGEMENT, L.P.10% OwnerOption ExerciseC0.001,741,35800
Mar 17 2020IMRAIMARA Inc.RA CAPITAL MANAGEMENT, L.P.10% OwnerBuyP16.00625,00010,000,0001,454,348829.3 K to 1.5 M (+75.36 %)
Mar 17 2020IMRAIMARA Inc.RA CAPITAL MANAGEMENT, L.P.10% OwnerBuyC0.00829,3480829,3480 to 829.3 K
Mar 13 2020KALAKala Pharmaceutica ...RA CAPITAL MANAGEMENT, L.P.DirectorBuyP7.896,337,13549,999,99510,874,6134.5 M to 10.9 M (+139.66 %)

View all RA CAPITAL MANAGEMENT, LLC insider transactions.